<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">avk</journal-id><journal-title-group><journal-title xml:lang="ru">Архивъ внутренней медицины</journal-title><trans-title-group xml:lang="en"><trans-title>The Russian Archives of Internal Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2226-6704</issn><issn pub-type="epub">2411-6564</issn><publisher><publisher-name>“SINAPS” LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20514/2226-6704-2025-15-2-151-160</article-id><article-id custom-type="elpub" pub-id-type="custom">avk-1963</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>РАЗБОР КЛИНИЧЕСКИХ СЛУЧАЕВ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ANALYSIS OF CLINICAL CASES</subject></subj-group></article-categories><title-group><article-title>Клинический случай первичной надпочечниковой недостаточности: трудности диагностики, терапевтическая тактика</article-title><trans-title-group xml:lang="en"><trans-title>Clinical Case of Primary Adrenal Insufficiency: Diagnostic Difficulties, Therapeutic Tactics</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8170-0863</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Саможенова</surname><given-names>П. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Samozhenova</surname><given-names>P. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Саможенова Полина Сергеевна — аспирант кафедры терапии и профилактической медицины</p><p>Москва</p></bio><bio xml:lang="en"><p>Polina S. Samozhenova — Postgraduate student of the Department of Therapy and Preventive Medicine</p><p>Moscow</p></bio><email xlink:type="simple">samozhenowapolina@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-4149-9497</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Губернаторова</surname><given-names>Е. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Gubernatorova</surname><given-names>E. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Губернаторова Екатерина Евгеньевна — к.м.н., ассистент кафедры терапии и профилактической медицины</p><p>Москва</p></bio><bio xml:lang="en"><p>Ekaterina E. Gubernatorova — Candidate of Medical Sciences, Assistant of the Department of Therapy and Preventive Medicine</p><p>Moscow</p></bio><email xlink:type="simple">creati-veone@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3763-8994</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Адашева</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Adasheva</surname><given-names>T. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>дашева Татьяна Владимировна — д.м.н., профессор, профессор кафедры терапии и профилактической медицины</p><p>Москва</p></bio><bio xml:lang="en"><p>Tatyana V. Adasheva — Doctor of Medical Sciences, Professor of the Department of Therapy and Preventive Medicine</p><p>Moscow</p></bio><email xlink:type="simple">adashtv@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7536-7937</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Горулева</surname><given-names>Е. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Goruleva</surname><given-names>E. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Горулева Екатерина Игоревна — к.м.н., доцент кафедры внутренних болезней Медицинского университета «Реавиз»; заведующая отделением терапии Больницы Центросоюза РФ</p><p>Москва</p></bio><bio xml:lang="en"><p>Ekaterina I. Goruleva — Candidate of Medical Sciences, Associate Professor of the Department of Internal Medicine at the Reaviz Medical University, Head of the Therapy Department at the Centrosoyuz Hospital of the Russian Federation</p><p>Moscow</p></bio><email xlink:type="simple">ekat-erina.gorulyova@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3426-1853</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лобанова</surname><given-names>Е. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Lobanova</surname><given-names>E. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лобанова Елена Георгиевна — д.м.н., профессор кафедры фармакологии</p><p>Москва</p></bio><bio xml:lang="en"><p>Elena G. Lobanova — Doctor of Medical Sciences, Professor of the Department of Pharmacology Federal State Budgetary Educational Institution of Higher Education “Russian University of Medicine” of the Ministry of Health of the Russian Federation</p><p>Moscow</p></bio><email xlink:type="simple">e.g.lobanova@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Российский университет медицины» Минздрава России, кафедра терапии и профилактической медицины</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal State Budgetary Educational Institution of Higher Education “Russian University of Medicine” of the Ministry of Health of the Russian Federation, department of Therapy and Preventive Medicine</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Больница Центросоюза Российской Федерации; Медицинский институт «Реавиз», кафедра внутренних болезней</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Hospital of the Centrosoyuz of the Russian Federation; Reaviz Medical Institute, department of Internal Medicine</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБОУ ВО «Российский университет медицины» Минздрава России, кафедра фармакологии</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal State Budgetary Educational Institution of Higher Education “Russian University of Medicine” of the Ministry of Health of the Russian Federation, department of pharmacology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>25</day><month>03</month><year>2025</year></pub-date><volume>15</volume><issue>2</issue><elocation-id>151_160</elocation-id><permissions><copyright-statement>Copyright &amp;#x00A9; Саможенова П.С., Губернаторова Е.Е., Адашева Т.В., Горулева Е.И., Лобанова Е.Г., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Саможенова П.С., Губернаторова Е.Е., Адашева Т.В., Горулева Е.И., Лобанова Е.Г.</copyright-holder><copyright-holder xml:lang="en">Samozhenova P.S., Gubernatorova E.E., Adasheva T.V., Goruleva E.I., Lobanova E.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.medarhive.ru/jour/article/view/1963">https://www.medarhive.ru/jour/article/view/1963</self-uri><abstract><p>Туберкулезное поражение надпочечников — редка я причина первичной надпочечниковой недостаточности (ПНН), характеризующаяся недостаточной выработкой глюкокортикоидов, минералокортикоидов и андрогенов. Неспецифическая симптоматика ПНН затрудняет своевременную диагностику и лечение, что нередко приводит к жизнеугрожающему состоянию — аддисоническому кризу. В данной статье представлено клиническое наблюдение пациентки 67 лет. В течение 8 месяцев пациентка отмечала постепенное нарастание общей слабости, снижение аппетита. При обращении в клинику по месту жительства в июне 2022 г. был установлен диагноз «синдром раздраженного кишечника». Состояние при госпитализации в терапевтическом отделении в октябре 2022 г: выраженная общая слабость, появление боли в животе, мышечные боли, тошнота, рвота. Учитывая вышеперечисленные симптомы, был заподозрен аддисонический криз. Не дожидаясь результатов диагностического поиска, пациентке было назначено введение гидрокортизона 100 мг внутривенно струйно 4 раза за сутки. По результатам исследований, у пациентки была подтверждена первичная надпочечниковая недостаточность, вызванная туберкулезным процессом. Пациентке была назначена заместительная гормональная терапия, проведена беседа о принципах самостоятельной коррекции гормональной терапии и рекомендована консультация врачом-фтизиатром для решения вопроса об инициировании противотуберкулезной терапии. На фоне терапии (межлекарственного взаимодействия) и диагностических процедур (бронхоскопия) и при отсутствии коррекции заместительной гормональной терапии у пациентки развился аддисонический криз. После купирования острого состояния, пациентка повторно консультирована врачом-эндокринологом: принято решение увеличить дозировку заместительной гормональной терапии на фоне лечения противотуберкулезными препаратами. Представленный клинический случай демонстрирует не только особенности диагностики и подбора заместительной терапии при лечении ПНН, но и необходимость повышения осведомленности врачей различных специальностей об алгоритме и тактике ведения пациентов с признаками аддисонического криза.</p></abstract><trans-abstract xml:lang="en"><p>Tuberculous adrenal insufficiency is a rare cause of primary adrenal insufficiency (PAI), characterized by insufficient production of glucocorticoids, mineralocorticoids, and androgens. Nonspecific symptoms of PAI complicate timely diagnosis and treatment, which often leads to a life-threatening condition, Addisonian crisis. This article presents a clinical observation of a 67-year-old female patient. For 8 months, the patient noted a gradual increase in general weakness, and decreased appetite. When visiting a local clinic in June 2022, she was diagnosed with irritable bowel syndrome. Condition on admission in the medical ward in October 2022 was manifested as severe general weakness, abdominal pain, muscle pain, nausea, vomiting. Given the above symptoms, Addisonian crisis was suspected. Before the results of diagnostic tests were obtained, the patient was given hydrocortisone 100 mg intravenously by jet stream 4 times per day. Based on the test results, the patient was diagnosed with primary adrenal insufficiency caused by a tuberculosis process. The patient was prescribed hormone replacement therapy, she was advised on the principles of independently adjusting the hormone therapy; a consultation with a TB specialist was also recommended to decide on initiating anti-tuberculosis therapy. The patient developed an Addisonian crisis due to a combination of factors: the treatment (the drug interaction), the impact of diagnostic procedures (bronchoscopy) and due to no correction of the prescribed hormone replacement therapy. After the acute condition was relieved, the patient was re-consulted by the endocrinologist who decided to increase the dosage of hormone replacement therapy and continue the treatment with antitubercular agents. This clinical case has demonstrated the specifics of diagnostics and selection of replacement therapy in the treatment of PNI. It has also shown that doctors of various specialties have to be better informed about the algorithm and tactics of managing patients with symptoms of Addisonian crisis.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>туберкулез надпочечников</kwd><kwd>первичная надпочечниковая недостаточность</kwd><kwd>аддисонический криз</kwd><kwd>болезнь Аддисона</kwd></kwd-group><kwd-group xml:lang="en"><kwd>adrenal tuberculosis</kwd><kwd>primary adrenal insufficiency</kwd><kwd>Addison crisis</kwd><kwd>Addison’s disease</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Российская Ассоциация Эндокринологов. Клинические рекомендации: Первичная надпочечниковая недостаточность. 2021</mixed-citation><mixed-citation xml:lang="en">Russian Associacion of Endocrinologist. Clinical practice guidelines: Primary adrenal insufflciency. 2021 [In Russian]</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Eystein S Husebye, Simon H Pearce, Nils P Krone, et al. Adrenal insufficiency. Lancet. 2021; 397: 613–629: DOI: 10.1016/S0140-6736(21)00136-7</mixed-citation><mixed-citation xml:lang="en">Eystein S Husebye, Simon H Pearce, Nils P Krone, et al. Adrenal insufficiency. Lancet. 2021; 397: 613–629: DOI: 10.1016/S0140-6736(21)00136-7</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Papadopoulos AS, Cleare AJ. Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome. Nat Rev Endocrinol. 2011 Sep 27;8(1):22-32. doi: 10.1038/nrendo.2011.153.</mixed-citation><mixed-citation xml:lang="en">Papadopoulos AS, Cleare AJ. Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome. Nat Rev Endocrinol. 2011 Sep 27;8(1):22-32. doi: 10.1038/nrendo.2011.153.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Gupta S, Ansari MAM, Gupta AK, et al. Current Approach for Diagnosis and Treatment of Adr enal Tuberculosis-Our Experience and Review of Literature. International Surgery Journal. 2022. 8(1): e92-e97. DOI: 10.1055/s-0042-1743523</mixed-citation><mixed-citation xml:lang="en">Gupta S, Ansari MAM, Gupta AK, et al. Current Approach for Diagnosis and Treatment of Adr enal Tuberculosis-Our Experience and Review of Literature. International Surgery Journal. 2022. 8(1): e92-e97. DOI: 10.1055/s-0042-1743523</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Справочник Видаль «Лекарственные препараты в России». Рифампицин (RIFAMPICIN) описание. URL: https://www.vidal.ru/drugs/molecule/925 (дата обращения: 20.07.24).</mixed-citation><mixed-citation xml:lang="en">Vidal Directory ‘Medicines in Russia’. Rifampicin (RIFAMPICIN) description. URL: https://www.vidal.ru/drugs/molecule/925 (date of the application: 20.07.24). [In Russian]</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">van Haren Noman S, Visser H, Muller AF,et al. Addison’s Disease Caused by Tuberculosis: Diagnostic and Therapeutic Difficulties. European Journal of Case Reports in Internal Medicine. 2018. 5(8):000911. doi: 10.12890/2018_000911.</mixed-citation><mixed-citation xml:lang="en">van Haren Noman S, Visser H, Muller AF,et al. Addison’s Disease Caused by Tuberculosis: Diagnostic and Therapeutic Difficulties. European Journal of Case Reports in Internal Medicine. 2018. 5(8):000911. doi: 10.12890/2018_000911.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao N, Gao Y, Ni C, Zhang D, et al. An autopsy case of unexpected death due to Addison’s disease caused by adrenal tuberculosis. European Journal of Medical Research. 2021 Dec 4;26(1):137. doi: 10.1186/s40001-021-00611-w.</mixed-citation><mixed-citation xml:lang="en">Zhao N, Gao Y, Ni C, Zhang D, et al. An autopsy case of unexpected death due to Addison’s disease caused by adrenal tuberculosis. European Journal of Medical Research. 2021 Dec 4;26(1):137. doi: 10.1186/s40001-021-00611-w.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
